Bipolar Disorder to be Treated with New Capsule Launched by Taizhou Firm

To be launched soon, the new capsule from China Medical City-based Changtai Pharmaceutical is suitable for the onset of type I bipolar disorder and refractory depression. Full story via this link. #nanjingermagazine #南京人杂志 #taizhou #泰州 #jiangsu #江苏